tirzepatide alternative titration dosing regimens of GLP‐1 receptor agonists may reduce costs and maintain weight loss efficacy - Cengiz - 2025 - Diabetes, Obesity and Metabolism Titration schedule and Cost :
Description
10.1124/dmd.114.059121 [DOI] [PubMed] [Google Scholar] Khalil F., Ler S

Rated 5 out of 5 Anonymous (verified owner) I absolutely love this medicine

MAD doses ranged from 0.2 to 0.6 mg once weekly for 6 weeks (ClinicalTrials.gov Identifier: NCT04389775)

Insurance coverage varies and is not guaranteed

At the 9mg dose, 8.8% of participants experienced dysesthesia
